BACKGROUND: In mouse models for metastatic growth of colorectal carcinoma (CRC) cells in the liver, tumor growth is routinely measured by determining the area of liver tissue that has been replaced by tumor tissue (hepatic replacement area [HRA]). This technique has several major disadvantages. Modern visualization techniques make it possible to image tumor growth noninvasively. In the present report, we validated bioluminescence imaging of liver metastases by comparing it to standard HRA measurements and liver weight. MATERIALS AND METHODS: BALB/c mice received an intrasplenic injection of luciferase-expressing C26 CRC cells and the spleen was subsequently removed. On days 5, 7, 9, and 11 after injection, luciferase activity was measured. After imaging, the mice were sacrificed and the livers was removed, weighed, and fixed. HRA was determined by analyzing liver tissue sections. Comparative trend analyses between luciferase activity, wet liver weight, and HRA were then performed. RESULTS: Luciferase activity, wet liver weight, and HRA all increased over time. Statistical analyses showed that all three types of measurements display a highly significant degree of correlation. CONCLUSIONS: The measurement of tumor growth in the liver by imaging luciferase activity correlates well with the standard method of determining the HRA and with the increase in liver weight that results from tumor growth. Given the great advantages of measuring luciferase activity over measuring HRA, we conclude that bioluminescent imaging is a reliable and superior method for measuring experimental CRC growth in the liver.
BACKGROUND: In mouse models for metastatic growth of colorectal carcinoma (CRC) cells in the liver, tumor growth is routinely measured by determining the area of liver tissue that has been replaced by tumor tissue (hepatic replacement area [HRA]). This technique has several major disadvantages. Modern visualization techniques make it possible to image tumor growth noninvasively. In the present report, we validated bioluminescence imaging of liver metastases by comparing it to standard HRA measurements and liver weight. MATERIALS AND METHODS: BALB/c mice received an intrasplenic injection of luciferase-expressing C26 CRC cells and the spleen was subsequently removed. On days 5, 7, 9, and 11 after injection, luciferase activity was measured. After imaging, the mice were sacrificed and the livers was removed, weighed, and fixed. HRA was determined by analyzing liver tissue sections. Comparative trend analyses between luciferase activity, wet liver weight, and HRA were then performed. RESULTS: Luciferase activity, wet liver weight, and HRA all increased over time. Statistical analyses showed that all three types of measurements display a highly significant degree of correlation. CONCLUSIONS: The measurement of tumor growth in the liver by imaging luciferase activity correlates well with the standard method of determining the HRA and with the increase in liver weight that results from tumor growth. Given the great advantages of measuring luciferase activity over measuring HRA, we conclude that bioluminescent imaging is a reliable and superior method for measuring experimental CRC growth in the liver.
Authors: Go Oshima; Melinda E Stack; Sean C Wightman; Darren Bryan; Elizabeth Poli; Lai Xue; Kinga B Skowron; Abhineet Uppal; Sean P Pitroda; Xiaona Huang; Mitchell C Posner; Samuel Hellman; Ralph R Weichselbaum; Nikolai N Khodarev Journal: J Vis Exp Date: 2016-11-30 Impact factor: 1.355
Authors: Noah Craft; Kevin W Bruhn; Bidong D Nguyen; Robert Prins; Linda M Liau; Eric A Collisson; Abhijit De; Michael S Kolodney; Sanjiv S Gambhir; Jeff F Miller Journal: J Invest Dermatol Date: 2005-07 Impact factor: 8.551
Authors: Prachi Pandit; Samuel M Johnston; Yi Qi; Jennifer Story; Rendon Nelson; G Allan Johnson Journal: Acad Radiol Date: 2013-04 Impact factor: 3.173
Authors: Ernst J A Steller; Danielle A Raats; Jan Koster; Bert Rutten; Klaas M Govaert; Benjamin L Emmink; Nikol Snoeren; Sander R van Hooff; Frank C P Holstege; Coen Maas; Inne H M Borel Rinkes; Onno Kranenburg Journal: Neoplasia Date: 2013-02 Impact factor: 5.715
Authors: Kei Hiraoka; Takahiro Kimura; Christopher R Logg; Chien-Kuo Tai; Kazunori Haga; Gregory W Lawson; Noriyuki Kasahara Journal: Cancer Res Date: 2007-06-01 Impact factor: 12.701
Authors: Sanjay Tiwari; Jan H Egberts; Olena Korniienko; Linda Köhler; Anna Trauzold; Claus C Glüer; Holger Kalthoff Journal: BMC Med Imaging Date: 2011-06-23 Impact factor: 1.930